Summit Therapeutics (SMMT) Cash from Investing Activities Growth (1y) (2018 - 2026)
Summit Therapeutics (SMMT) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Summit Therapeutics | 10.29 Bn | 9.60 Bn | - | 47.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.80% |
| Mar 31, 2026 | -100.15% |
| Dec 31, 2025 | -681.15% |
| Sep 30, 2025 | 99.93% |
| Jun 30, 2025 | 175.37% |
| Mar 31, 2025 | 705.75% |
| Dec 31, 2024 | 37.83% |
| Sep 30, 2024 | -3,015.75% |
| Jun 30, 2024 | -96,756.52% |
| Mar 31, 2024 | 103.08% |
| Dec 31, 2023 | 605,580.00% |
| Sep 30, 2023 | -17,530.00% |
| Jun 30, 2023 | 170.65% |
| Mar 31, 2023 | -178,587.81% |
| Dec 31, 2022 | 108.33% |
| Sep 30, 2022 | 400.00% |
| Jun 30, 2022 | -94.04% |
| Mar 31, 2022 | -825.64% |
| Dec 31, 2021 | -140.00% |
| Sep 30, 2021 | 109.09% |